C V Prasad - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

C V Prasad

Showing results (21-30 of 22) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 22 results.

Journal of Medicinal Chemistry|November 11, 1994

Aspartyl alpha-((1-phenyl-3-(trifluoromethyl)-pyrazol-5-yl)oxy)methyl ketones as interleukin-1 beta converting enzyme inhibitors. Significance of the P1 and P3 amido nitrogens for enzyme-peptide inhibitor bindingR E Dolle, J Singh, J Rinker, et al.

Journal of Medicinal Chemistry|June 20, 1997

Pyridazinodiazepines as a high-affinity, P2-P3 peptidomimetic class of interleukin-1 beta-converting enzyme inhibitorR E Dolle, C V Prasad, C P Prouty, et al.

Pageof 3

Search research articles

Showing results (21-30 of 22) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 22 results.

Journal of Medicinal Chemistry|November 11, 1994

Aspartyl alpha-((1-phenyl-3-(trifluoromethyl)-pyrazol-5-yl)oxy)methyl ketones as interleukin-1 beta converting enzyme inhibitors. Significance of the P1 and P3 amido nitrogens for enzyme-peptide inhibitor bindingR E Dolle, J Singh, J Rinker, et al.

Journal of Medicinal Chemistry|June 20, 1997

Pyridazinodiazepines as a high-affinity, P2-P3 peptidomimetic class of interleukin-1 beta-converting enzyme inhibitorR E Dolle, C V Prasad, C P Prouty, et al.

Pageof 3